Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP266413.RAF6vHFT-xttWnUAkr6wVJZCw1KQDAQM3TXN9NLt-I3Oo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP266413.RAF6vHFT-xttWnUAkr6wVJZCw1KQDAQM3TXN9NLt-I3Oo130_assertion type Assertion NP266413.RAF6vHFT-xttWnUAkr6wVJZCw1KQDAQM3TXN9NLt-I3Oo130_head.
- NP266413.RAF6vHFT-xttWnUAkr6wVJZCw1KQDAQM3TXN9NLt-I3Oo130_assertion description "[The influence of pharmacological treatment on the immune response of patients with Echinococcus granulosus infection was evaluated by reverse transcriptase-polymerase chain reaction (RT-PCR) to determine mRNA expression for IL-12 p35, IL-12 p40, interferon-gamma (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha) and IL-4 in PBMC from 12 patients before and after chemotherapy and from seven uninfected controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP266413.RAF6vHFT-xttWnUAkr6wVJZCw1KQDAQM3TXN9NLt-I3Oo130_provenance.
- NP266413.RAF6vHFT-xttWnUAkr6wVJZCw1KQDAQM3TXN9NLt-I3Oo130_assertion evidence source_evidence_literature NP266413.RAF6vHFT-xttWnUAkr6wVJZCw1KQDAQM3TXN9NLt-I3Oo130_provenance.
- NP266413.RAF6vHFT-xttWnUAkr6wVJZCw1KQDAQM3TXN9NLt-I3Oo130_assertion SIO_000772 10540165 NP266413.RAF6vHFT-xttWnUAkr6wVJZCw1KQDAQM3TXN9NLt-I3Oo130_provenance.
- NP266413.RAF6vHFT-xttWnUAkr6wVJZCw1KQDAQM3TXN9NLt-I3Oo130_assertion wasDerivedFrom befree-2016 NP266413.RAF6vHFT-xttWnUAkr6wVJZCw1KQDAQM3TXN9NLt-I3Oo130_provenance.
- NP266413.RAF6vHFT-xttWnUAkr6wVJZCw1KQDAQM3TXN9NLt-I3Oo130_assertion wasGeneratedBy ECO_0000203 NP266413.RAF6vHFT-xttWnUAkr6wVJZCw1KQDAQM3TXN9NLt-I3Oo130_provenance.